v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 27, 2026
Mar. 28, 2025
Mar. 29, 2024
Cash flows from operating activities:      
Net (loss) income $ (14,653) $ (72,763) $ 152,888
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 67,593 64,502 71,382
Amortization of deferred financing costs 2,245 2,513 527
Deferred income taxes (11,994) (16,301) (18,613)
Stock-based compensation 47,910 41,868 42,457
Loss on change in fair value of forward repurchase contract 0 34,752 0
Impairment of assets held for sale 6,590 0 0
Impairment of long-lived assets 0 0 13,218
Provisions for inventory and expected credit losses 10,011 9,216 10,286
Change in fair value of marketable securities 0 0 3,579
Other non-cash reconciling items 653 6,984 70
Changes in operating assets and liabilities:      
Trade accounts receivable (9,201) 33,081 (7,964)
Accounts receivable - other (9,805) 155 (1,035)
Inventories (6,267) (30,160) (15,848)
Payment to related party (15,000) 0 0
Prepaid expenses and other assets 49,417 (4,756) (40,231)
Trade accounts payable 5,996 4,044 (12,653)
Due to and from related party (1,740) 5,115 5,231
Other changes in operating assets and liabilities, net 41,314 (16,337) (21,579)
Net cash provided by operating activities 163,069 61,913 181,715
Cash flows from investing activities:      
Purchases of property, plant and equipment (38,176) (39,955) (124,772)
Purchases of intangible assets 0 (1,180) 0
Acquisition of business, net of cash acquired and working capital adjustment 0 319 (408,119)
Investment in debt security (3,541) 0 0
Sales in marketable securities 0 0 16,175
Net cash used in investing activities (41,717) (40,816) (516,716)
Cash flows from financing activities:      
Borrowings of 2023 term loan facility, net of deferred financing costs 0 0 245,452
Repayment of 2020 term loan facility 0 0 (25,000)
Net proceeds from 2026 Refinanced Term Loan Facility 285,000 193,081 0
Repayment of term loan (345,000) (105,000) (625)
Repayments of other debt 0 0 (842)
Finance lease payments (1,368) (1,201) (142)
Receipts on related party notes receivable 0 1,875 3,750
Payments for intangible assets (5,000) 0 0
Payments for taxes related to net share settlement of equity awards (12,612) (16,238) (25,900)
Proceeds from issuance of common stock under employee purchase plan 3,337 3,511 3,635
Repurchases of common stock 0 (853,921) 0
Net proceeds from issuance of common stock 0 665,850 0
Payments for taxes related to repurchase of common stock (1,713) 0 0
Dividends paid to non-controlling interest (23) (19) 0
Payments of debt issuance costs 0 0 (1,450)
Net cash (used in) provided by financing activities (77,379) (112,062) 198,878
Effect of exchange rate changes on cash and cash equivalents and restricted cash 277 (89) (421)
Net increase (decrease) in cash and cash equivalents and restricted cash 44,250 (91,054) (136,544)
Cash and cash equivalents and restricted cash at beginning of period 131,107 222,161 358,705
Cash and cash equivalents and restricted cash at end of period: 175,357 131,107 222,161
Reconciliation of cash and cash equivalents and restricted cash:      
Cash and cash equivalents at beginning of period 121,334 212,143 351,576
Restricted cash at beginning of period 9,773 10,018 7,129
Cash and cash equivalents at end of period 168,753 121,334 212,143
Restricted cash at end of period 6,604 9,773 10,018
Supplemental disclosures of cash flow information:      
Cash paid for interest 19,375 21,959 10,153
Cash paid for income taxes, net of refunds (27,081) 11,639 89,927
Non-cash transactions:      
Property, plant and equipment purchases included in trade accounts payable and accrued expenses (3,961) (4,463) (4,157)
Right-of-use assets obtained in exchange for lease liabilities 1,584 6,999 10,450
Assets held for sale transferred from property, plant and equipment, net $ (9,751) $ 16,508 $ 0